Area of Focused Competency in Neuromuscular Medicine Approved by Royal College of Physicians and Surgeons of Canada

The Neuromuscular Disease Network for Canada (NMD4C) are pleased to announce that on May 3rd, 2022, the Royal College of Physicians and Surgeons of Canada approved an application for neuromuscular medicine to be recognized as an area of focused competency (AFC) discipline.

 “Our community is extremely excited to receive approval for this neuromuscular AFC. Through collaboration with clinical experts and Canadian neuromuscular fellowship program directors, this was a unified effort, the result of which contributes directly towards our goal of raising the standards of training for Canadian neuromuscular clinicians.”


– Dr. Hernan Gonorazky, Assistant Professor, Faculty of Medicine University of Toronto Division of Neurology, Department of Paediatrics.

 

This recognition is a significant step in raising the standards of care for people affected by neuromuscular diseases in Canada – prior to the approval of this AFC discipline, no dedicated credential focused solely on neuromuscular medicine existed in Canada. The AFC discipline in neuromuscular medicine establishes a national standard for training and specialist competence, provides neuromuscular fellows with additional opportunities to acquire nationally and internationally portable credentials, and will help to centralize specialty training, care, and practice by providing credentials in the highly focused area of neuromuscular practice. The Royal College’s AFC disciplines formally recognize and provide supplemental and advanced training within a specific area of medicine to enhance a clinician’s scope of practice, building on the broader disciplines of clinical specialties and subspecialties.

 

The Team Behind This Achievement

Led by Dr. Hernan Gonorazky, the NMD4C curriculum development team has been working on this Royal College AFC application over the past two years. Thanks to Drs. Aaron Izenberg, Christen Shoesmith, Kristine Chapman, Theo Mobach, Patrick Frosk, Jocelyn Zwicker, Alberto Aleman, Steven Baker, and all of the directors of Canadian neuromuscular fellowship programs who each contributed their expertise to this application, and without whose hard work this achievement would not have been possible. The NMD4C curriculum development working group are pleased to celebrate this milestone and are excited to work with the neuromuscular clinical community and the Royal College of Physicians and Surgeons towards implementing the AFC in neuromuscular medicine.

 

How to Achieve the Accreditation

The AFC in neuromuscular medicine has only recently been approved and has not yet been implemented by the Royal College. Once it is available, there are two pathways to achieve AFC credential and designation: the in-training route, through fellowships at medical schools with accredited AFC training programs, and the practice eligibility route (PER-AFC), for clinicians who have gained competence through their own practice. The PER-AFC is an application-based approval process.

For more information, please contact NMD4C Communications Coordinator Lola Owoeye at , or Curriculum development lead Dr. Hernan Gonorazky at .

Application for AFC in neuromuscular medicine approved by the Royal College

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.